Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–3 of 3 results
Advanced filters: Author: "Michael G Shlipak" Clear advanced filters

  • A growing number of studies in nephrology are focusing on biomarkers for chronic kidney disease (CKD). Here, Michael Shlipak and Erica Day describe biomarkers that are used to predict risk of developing CKD and outline the statistical methods that can be used to assess the performance of candidate biomarkers. The authors also provide a conceptual framework for interpreting the results of studies evaluating biomarkers of declining kidney function and incident CKD.

    • Michael G. Shlipak
    • Erica C. Day
    Reviews
    Nature Reviews Nephrology
    Volume: 9, P: 478-483

  • Despite reductions in morbidity and mortality owing to widespread use of highly effective antiretroviral therapy (ART), HIV-positive patients remain at high risk of chronic kidney disease (CKD) and end-stage renal disease. A new report provides a HIV-specific CKD risk score to balance the potential benefits and harms of nephrotoxic ART.

    • Rebecca Scherzer
    • Michael G. Shlipak
    News & Views
    Nature Reviews Nephrology
    Volume: 11, P: 392-393